William Garrett Gray
2021
In 2021, William Garrett Gray earned a total compensation of $748.1K as Chief Financial Officer, Corporate Secretary and Treasurer at Checkpoint Therapeutics, a 10% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $93,000 |
|---|---|
| Salary | $250,000 |
| Stock Awards | $397,130 |
| Other | $7,938 |
| Total | $748,068 |
Gray received $397.1K in stock awards, accounting for 53% of the total pay in 2021.
Gray also received $93K in non-equity incentive plan, $250K in salary and $7.9K in other compensation.
Rankings
In 2021, William Garrett Gray's compensation ranked 9,689th out of 12,415 executives tracked by ExecPay. In other words, Gray earned more than 22.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,689 out of 12,415 | 22nd |
Division Manufacturing | 4,292 out of 5,505 | 22nd |
Major group Chemicals And Allied Products | 1,902 out of 2,375 | 20th |
Industry group Drugs | 1,688 out of 2,096 | 20th |
Industry Pharmaceutical Preparations | 1,257 out of 1,546 | 19th |
Source: SEC filing on April 29, 2022.
Gray's colleagues
We found two more compensation records of executives who worked with William Garrett Gray at Checkpoint Therapeutics in 2021.
News
Checkpoint Therapeutics CEO James Oliviero's 2021 pay stays at $2.3M
April 29, 2022
Checkpoint Therapeutics CEO James Oliviero's 2020 pay slips 1% to $2.3M
April 30, 2021
Checkpoint Therapeutics CEO James Oliviero's 2019 pay rises 8% to $2.3M
April 24, 2020
Checkpoint Therapeutics CEO James Oliviero's 2018 pay jumps 230% to $2.1M
April 30, 2019